VKTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Viking Therapeutics (VKTX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VKTX is expected to report earnings to rise 4.28% to -33 cents per share on April 23

Viking Therapeutics VKTX Stock Earnings Reports

Q1'25

Est.

$-0.33

Q4'24

Missed

by $0.04

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.06

Q1'24

Beat

by $0.02

The last earnings report on February 05 showed earnings per share of -31 cents, missing the estimate of -28 cents. With 15.77M shares outstanding, the current market capitalization sits at 3.81B.

View a ticker or compare two or three

Compare

VKTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VKTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for VKTX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a company that engages in the development of therapies for metabolic and endocrine disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9920 Pacific Heights Boulevard

Phone

+1 858 704-4660

Employees

Web

https://www.vikingtherapeutics.com